Micronutrient Bioavailability From Wheat

NCT ID: NCT05536947

Last Updated: 2022-09-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

25 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-11-26

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if physical disruption of wheat aleurone cell walls (micro-milling) increases micronutrient availability.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This research project is a short-term dietary intervention study to investigate the bio-availability of iron and zinc from wheat. Approximately 50% of iron and 30% of zinc in the United Kingdom diet is provided by cereals and cereal products (e.g. bread and breakfast cereals). The localisation of both iron and zinc metals in wheat is largely confined to the aleurone layer, a single layer of cells located between the centre (endosperm) and outer layers (testa and pericarp). The aleurone layer is removed during the production of white flour. For this reason, since 1953 it has been mandatory to add iron to flours at the mill to restore iron to levels present in wholegrain flour (The Bread and Flour Regulations, 1998).

The investigators have shown that aleurone cells are resistant to physical disruption and digestion as they pass along the gastrointestinal tract and are excreted intact in faeces. The investigators believe that disruption of wheat aleurone cell walls prior to food manufacturing would therefore increase iron and zinc availability. Using wholegrain flour and purified wheat aleurone flour the investigators have shown that micro-milling, a process which reduces particle size of flour from approximately 100μm to 10μm, ruptures the aleurone cell walls, and increases iron availability, i.e. the amount absorbed by intestinal cells, compared with flour produced using standard milling techniques (which does not break down the aleurone layer).

Based on these initial findings, the current study therefore has 2 main aims:

(i) to determine whether physical disruption of the aleurone (by micro-milling) in wholegrain flour increases iron and zinc availability from wholegrain bread.

(ii) to determine whether addition of micro-milled aleurone flour to white flour increases iron availability from white bread.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard-milled Wholegrain

Bread rolls prepared using standard-milled Wholegrain (75 g per bread roll, containing stable isotopes of Fe and Zn), with butter and strawberry jam.

Group Type ACTIVE_COMPARATOR

Bread product (standard milled)

Intervention Type OTHER

Bread rolls made from standard milled flour.

Micro-milled Wholegrain

Bread rolls prepared using Micro-milled Wholegrain (75 g per bread roll, containing stable isotopes of Fe and Zn), with butter and strawberry jam.

Group Type EXPERIMENTAL

Bread Product (micro-milled)

Intervention Type OTHER

Bread rolls made from micro-milled whole grain flour.

White flour fortified with standard milled Aleurone

Bread rolls prepared using a white flour and standard-milled aleurone mix (75 g per bread roll, containing stable isotope of Fe), with butter and strawberry jam.

Group Type ACTIVE_COMPARATOR

Bread Product (standard aleurone)

Intervention Type OTHER

Bread rolls made from white flour/standard milled aleurone mix

White flour fortified with micro-milled Aleurone

Bread rolls prepared using a white flour and micro-milled aleurone mix (75 g per bread roll, containing stable isotope of Fe), with butter and strawberry jam.

Group Type EXPERIMENTAL

Bread product (micro-milled aleurone)

Intervention Type OTHER

Bread rolls made from white flour/micro-milled aleurone mix.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bread product (standard milled)

Bread rolls made from standard milled flour.

Intervention Type OTHER

Bread Product (micro-milled)

Bread rolls made from micro-milled whole grain flour.

Intervention Type OTHER

Bread Product (standard aleurone)

Bread rolls made from white flour/standard milled aleurone mix

Intervention Type OTHER

Bread product (micro-milled aleurone)

Bread rolls made from white flour/micro-milled aleurone mix.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy pre-menopausal women
* Serum ferritin below 30 μg/L
* Plasma zinc below 13.8 μmol/L.

Exclusion Criteria

* Allergic to gluten or wheat
* Pregnant
* Post-menopausal women
* History of alcohol or substance abuse
* History of Cardiovascular Disease, diabetes, cancer, kidney, liver or intestinal disease, gastrointestinal disorder or use of drugs likely to alter gastrointestinal function.
* Donated blood recently (within 3 months prior to screening visit)
* Volunteers planning to take any mineral or vitamin supplements during the course of the study.
Minimum Eligible Age

19 Years

Maximum Eligible Age

49 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

King's College London

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Paul A Sharp, PhD

Role: PRINCIPAL_INVESTIGATOR

King's College London, Department of Nutritional Sciences

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

King's College London

London, , United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mohamad F Aslam, PhD

Role: CONTACT

020 7836 5454

Paul A Sharp, PhD

Role: CONTACT

020 7836 5454

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mohamad Farshard C Aslam, PhD

Role: primary

02078484331

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HR-18/19-5718

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

How Healthy Are Your Oats?
NCT07050680 RECRUITING NA
Food or Supplemental Lutein Absorption
NCT04786392 WITHDRAWN PHASE1